Management

  • Rainer Lichtenberger, Ph.D. MBA
    CEO

    25 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 12 years CEO/COO experience in several SME, raised € 35 Mn venture funds.

    Read more
  • Christian Wallasch, Ph.D.
    COO

    Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.

    Read more
  • Martin Bauer, M.D., FNWC
    Acting CMO

    Board certified anesthetist with more than 15 years in industrial research and development. Senior management positions at Merck, Basilea, ICON, Otsuka in the past.

    Read more
  • Prof. Oliver Planz, Ph.D.
    CSO

    Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

    Read more
  • Björn Cochlovius, Ph.D., Assoc. Prof.
    VP Business Development

    20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, Financing

    Read more
  • 1

Address

Atriva Therapeutics GmbH
Christophstr. 32, 72072 Tübingen

+49 (0)7071 8597673
info@atriva-therapeutics.com

LinkedIn
Twitter

In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.